E030019B06Rik, a gene with currently undefined function, emerges as a pivotal player in cellular processes, showcasing its intricate involvement in various signaling pathways and cellular dynamics. While the precise role of E030019B06Rik remains elusive, its activation appears to be closely tied to several key mechanisms, shedding light on its potential impact on cellular functions. The activation of E030019B06Rik seems to be influenced by a spectrum of regulatory elements, including epigenetic modifications. Histone deacetylase inhibitors, such as Sodium Butyrate and Trichostatin A, impact E030019B06Rik expression through chromatin remodeling. This suggests that the gene may be subject to transcriptional control mediated by changes in histone acetylation patterns, highlighting the significance of epigenetic regulation in shaping the cellular landscape.
Moreover, E030019B06Rik activation appears intricately connected to various signaling pathways. The MAPK pathway plays a crucial role in modulating E030019B06Rik expression, implicating the gene in cellular processes influenced by MAPK signaling. Additionally, cyclic AMP and calcium-mediated pathways, illustrated by 8-Bromo-cAMP and A23187, respectively, are implicated in E030019B06Rik activation, hinting at its involvement in cellular responses to cyclic AMP signaling and calcium fluxes. The activation of E030019B06Rik is intricately woven into the complex tapestry of cellular signaling, underscoring the need for further investigation to unravel its specific functions and contributions to cellular dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate, a histone deacetylase inhibitor, modulates chromatin structure. This epigenetic change influences E030019B06Rik expression by altering transcriptional regulation, highlighting the role of chromatin modifications in its activation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
8-Bromo-cAMP elevates cAMP levels, activating PKA. This kinase impacts E030019B06Rik expression via CREB, connecting cyclic AMP signaling to E030019B06Rik activation. The modulation highlights the role of cAMP-dependent pathways in E030019B06Rik regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, alters chromatin structure. Epigenetic changes induced by Trichostatin A influence E030019B06Rik expression, illustrating the link between DNA methylation dynamics and E030019B06Rik-mediated cellular processes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187, a calcium ionophore, elevates intracellular Ca2+ levels. Increased Ca2+ activates CaMKII, impacting E030019B06Rik expression through downstream pathways. This connection underscores the role of calcium signaling in E030019B06Rik regulation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin activates JNK, influencing E030019B06Rik expression through the JNK pathway. This modulation links stress-responsive pathways to E030019B06Rik activation, contributing to cellular responses involving E030019B06Rik. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid modulates retinoic acid receptors, affecting E030019B06Rik indirectly. This alters transcriptional regulation, influencing E030019B06Rik expression and involvement in cellular processes associated with retinoic acid signaling. | ||||||